ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Argentine securities regulators have rejected part of Braskem’s $290 million purchase of South American polyvinyl chloride maker Solvay Indupa. Last month, Braskem had agreed to purchase Solvay’s 71% interest in the firm, which trades publicly on the Buenos Aires Stock Exchange. Regulators say Braskem needs to come up with a more equitable tender offer than the 1.35 pesos, or 20 cents per share, which it is making to Indupa’s other shareholders. Indupa’s shares recently closed at 3.55 pesos. Braskem asserts that its offer is fair and represents a 153% premium over what it is offering Solvay for its shares.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter